The Fluorescent Cell Line SW620-GFP Is a Valuable Model to Monitor Magnetic Hyperthermia
- PMID: 39061720
- PMCID: PMC11274270
- DOI: 10.3390/bioengineering11070638
The Fluorescent Cell Line SW620-GFP Is a Valuable Model to Monitor Magnetic Hyperthermia
Abstract
In this work, the cell line SW620-GFP has been used in a complete magnetic hyperthermia assay, from the preparation of the ferrofluid with folate-coated iron oxide nanoparticles to in vivo experiments. The physical and chemical characterization of the nanoparticles evidenced their superparamagnetic behaviour, an average diameter of 12 ± 4 nm, a 2 nm coat thickness, and a high-power loss density. The main innovation of the work is the exclusive capability of viable SW620-GFP cells to emit fluorescence, enabling fast analysis of both, cell viability in vitro with an epifluorescence microscope and tumour size and shape in vivo in a non-invasive manner using the iBox technology. Moreover, with this imaging technique, it was possible to demonstrate the successful tumour size reduction in mice applying magnetic hyperthermia three times a week over 3 weeks.
Keywords: fluorescence; hyperthermia; nanoparticles.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures













References
-
- Study of Focal Ablation of the Prostate with NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer. [(accessed on 8 December 2023)]; Available online: https://clinicaltrials.gov/study/NCT05010759.
-
- Peiravi M., Eslami H., Ansari M., Zare-Zardini H. Magnetic hyperthermia: Potentials and limitations. J. Indian Chem. Soc. 2022;1:100269. doi: 10.1016/j.jics.2021.100269. - DOI
-
- Gavilán H., Avugadda S.K., Fernández-Cabada T., Soni N., Cassani M., Mai B.T., Chantrell R., Pellegrino T. Magnetic nanoparticles and clusters for magnetic hyperthermia: Optimizing their heat performance and developing combinatorial therapies to tackle cancer. Chem. Soc. Rev. 2021;50:11614–11667. doi: 10.1039/D1CS00427A. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources